Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
anthelmintic drug |
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
gptkb:P02BX06
|
| gptkbp:CASNumber |
gptkb:68786-66-3
|
| gptkbp:chemicalClass |
benzimidazole
|
| gptkbp:discoveredBy |
gptkb:Ciba-Geigy
|
| gptkbp:discoveredIn |
1970s
|
| gptkbp:eliminationHalfLife |
8 hours
|
| gptkbp:hasMolecularFormula |
C14H9Cl3N2OS
|
| https://www.w3.org/2000/01/rdf-schema#label |
triclabendazole
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits microtubule formation
|
| gptkbp:meltingPoint |
204-206°C
|
| gptkbp:organism |
gptkb:Fasciola_gigantica
gptkb:Fasciola_hepatica |
| gptkbp:PubChem_CID |
gptkb:DB00857
68786 CHEMBL1387 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting abdominal pain headache |
| gptkbp:synonym |
gptkb:Fasinex
Egaten |
| gptkbp:UNII |
2B6F4R1Y0X
|
| gptkbp:usedFor |
treatment of liver fluke infections
treatment of fascioliasis |
| gptkbp:WHOModelListOfEssentialMedicines |
yes
|
| gptkbp:bfsParent |
gptkb:liver_fluke
|
| gptkbp:bfsLayer |
6
|